|
Delayed
Liquidnet
|
5-day change | 1st Jan Change | ||
| - EUR | -.--% |
|
-0.40% | - |
| 08-24 | FTSE 100 outperforms as oil price heads lower | AN |
| 08-24 | European Stocks Close Mostly Lower in Monday Trading; US Treasury Secretary Scott Bessent to Give Details on Iran Sanctions | MT |
| Market Cap | 75.75B 103B 88.57B 82.86B 143B 9,896B 144B 980B 381B 4,969B 388B 380B 16,441B | P/E 2026 * |
14.3x | P/E 2027 * | 11.7x |
|---|---|---|---|---|---|
| Enterprise Value | 95.59B 130B 112B 105B 180B 12,487B 182B 1,237B 481B 6,270B 490B 479B 20,747B | EV / Sales 2026 * |
2.82x | EV / Sales 2027 * | 2.61x |
| Free-Float |
92.75% | Yield 2026 * |
3.68% | Yield 2027 * | 3.96% |
Last Transcript: GlaxoSmithKline plc
| Manager | Title | Age | Since |
|---|---|---|---|
Luke Miels
CEO | Chief Executive Officer | 52 | 2025-12-31 |
Julie Brown
DFI | Director of Finance/CFO | 64 | 2023-04-30 |
James Ford
CMP | Compliance Officer | - | 2018-07-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Luke Miels
BRD | Director/Board Member | 52 | 2026-05-05 |
Hal Barron
BRD | Director/Board Member | 64 | 2017-12-31 |
Jonathan Symonds
CHM | Chairman | 67 | 2019-08-31 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | -0.40% | - | - | 105B | |
| -0.67% | +5.39% | +75.21% | +127.54% | 1,119B | |
| +1.04% | +4.07% | +52.29% | +65.39% | 651B | |
| -0.17% | +5.67% | +25.60% | +80.40% | 468B | |
| -1.38% | +4.02% | +41.64% | +42.38% | 374B | |
| -0.52% | +2.72% | +24.32% | +41.06% | 302B | |
| -1.06% | +4.76% | +1.19% | +12.65% | 259B | |
| +1.03% | +5.83% | +51.11% | +72.96% | 238B | |
| -0.53% | +2.34% | -17.77% | -53.66% | 208B | |
| +0.42% | +5.63% | +27.86% | +92.24% | 181B | |
| Average | -0.18% | +4.81% | +31.27% | +53.44% | 422.21B | |
| Weighted average by Cap. | -0.23% | +4.95% | +43.93% | +72.99% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 33.94B 46.3B 39.68B 37.12B 64.04B 4,433B 64.72B 439B 171B 2,226B 174B 170B 7,365B | 35.52B 48.45B 41.52B 38.85B 67.02B 4,640B 67.73B 460B 179B 2,330B 182B 178B 7,708B |
| Net income | 5.44B 7.42B 6.36B 5.95B 10.26B 710B 10.37B 70.35B 27.36B 357B 27.84B 27.24B 1,180B | 6.48B 8.85B 7.58B 7.09B 12.24B 847B 12.37B 83.93B 32.63B 425B 33.22B 32.5B 1,407B |
| Net Debt | 19.84B 27.07B 23.19B 21.7B 37.44B 2,592B 37.83B 257B 99.84B 1,301B 102B 99.42B 4,306B | 17.06B 23.27B 19.95B 18.66B 32.19B 2,229B 32.54B 221B 85.86B 1,119B 87.39B 85.5B 3,703B |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- GSK Stock
- GSK Stock
Select your edition
All financial news and data tailored to specific country editions
